Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:51 PM
Ignite Modification Date:
2025-12-24 @ 5:51 PM
NCT ID:
NCT01637168
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of two different drugs in the treatment of patients diagnosed with memory difficulties and a decline in cognitive function.
This is a parallel distribution: a group of patients will be treated with a combination Panax Ginseng + Ginkgo Biloba + multivitamin + Polyminerals (EMS), and another group with Ginkgo Biloba (Tebonin ®).
Detailed Description:
STUDY DESIGN:
* multicenter, phase III, double-blind, randomized entry of patients, prospective and comparative
* The duration of the study: 60 days
* 3 visits (days 1, 30 and 60)
* Evaluate the effectiveness of the association
* Evaluate the safety of the combination
* Adverse events evaluation
Study:
NCT01637168
Study Brief:
Protocol Section:
NCT01637168